Company: INVUP
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001641172-25-010230
Chunk: 31

Company: Investview, Inc.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part I, Item 1
Chunk 31
---
.

In November of 2020, we entered into notes with third parties for $19,089,500 in exchange for the cancellation of APEX leases previously
entered into, which resulted in our purchase of all rights and obligations under the leases. We agreed to settle a portion of the debt
during the year ended March 31, 2021, at a discount to the original note terms offered, by making lump sum payments, issuing 48,000,000
shares of our common stock, issuing 49,418 shares of our preferred stock, and issuing digital assets. The remaining notes were due December
31, 2024, and had a fixed monthly payment that is equal to 75% of the face value of the note, divided by 48 months. The monthly payments
began the last day of January 2021 and continued until December 31, 2024, when the last monthly payment was made, along with a balloon
payment equal to 25% of the face value of the note, to extinguish the debt. During the fourth quarter ended December 31, 2023, we offered
all note holders an early payoff option. During the three months ended March 31, 2024, we repaid a portion of the debt with cash payments
of $106,950 and issuances of digital assets then valued at $38,767. As of December 31, 2024, the debt was paid in full.

NOTE 8 – DERIVATIVE LIABILITY

During the three months ended March 31, 2025, we had the following activity
in our derivative liability account relating to our warrants:

SCHEDULE OF DERIVATIVE LIABILITY 

    Derivative liability at December 31, 2024
    $
    758

    Derivative liability recorded on new instruments
     
    -

    Derivative liability reduced by warrant exercise 
     
    -

    (Gain) loss on fair value
     
    2,095

    Derivative liability at March 31, 2025
    $
    2,853

    19

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

We use the binomial option pricing model to estimate
fair value for those instruments at inception, at warrant exercise, and at each reporting date. During the three months ended March 31,
2025